These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34177016)

  • 21. Corporate governance mechanisms, royal family ownership and corporate performance: evidence in gulf cooperation council (GCC) market.
    Tawfik OI; Alsmady AA; Rahman RA; Alsayegh MF
    Heliyon; 2022 Dec; 8(12):e12389. PubMed ID: 36636223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managerial Myopia and Firm Green Innovation: Based on Text Analysis and Machine Learning.
    Liu X
    Front Psychol; 2022; 13():911335. PubMed ID: 35795435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Functions of the Board of Directors in Corporate Philanthropy: An Empirical Study From China.
    Pan Q; Huang Z
    Front Psychol; 2022; 13():850980. PubMed ID: 35686082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corporate climate risk and stock market reaction to performance briefings in China.
    Wu N; Xiao W; Liu W; Zhang Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53801-53820. PubMed ID: 35290587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Chief Executives Matter in Corporate Financial and Social Responsibility Performance Nexus? A dynamic Model Analysis of Chinese Firms.
    Zahid RMA; Khurshid M; Khan W
    Front Psychol; 2022; 13():897444. PubMed ID: 35712198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "Booster" of Corporate Eco-Innovation: Government Pressure Perceived by Chinese Private Firms.
    Li C
    J Environ Public Health; 2022; 2022():2337867. PubMed ID: 36193399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corporate philanthropy, political influence, and health policy.
    Fooks GJ; Gilmore AB
    PLoS One; 2013; 8(11):e80864. PubMed ID: 24312249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shaking things up or business as usual? The influence of female corporate executives and board of directors on women's managerial representation.
    Skaggs S; Stainback K; Duncan P
    Soc Sci Res; 2012 Jul; 41(4):936-48. PubMed ID: 23017861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CEO financial background, managerial ownership, and corporate innovation: Insights from imprinting theory.
    Gao Y; Tang Y; Zhang J
    Front Psychol; 2023; 14():1126853. PubMed ID: 36865362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How does Chinese central environmental inspection affect corporate green innovation? The moderating effect of bargaining intentions.
    Zhang Z; Peng X; Yang L; Lee S
    Environ Sci Pollut Res Int; 2022 Jun; 29(28):42955-42972. PubMed ID: 35092589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sincerity or hypocrisy: can green M&A achieve corporate environmental governance?
    Zhao X; Jia M
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):27339-27351. PubMed ID: 34978031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naive independent directors, corporate governance and firm performance.
    Chen G; Chen X; Wan P
    Front Psychol; 2022; 13():984661. PubMed ID: 36118473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting the "Love of Humanity" Back in Corporate Philanthropy: The Case of Health Grants by Corporate Foundations.
    Boodoo MU; Henriques I; Husted BW
    J Bus Ethics; 2022; 178(2):415-428. PubMed ID: 33867605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness.
    Li H; Zhang H; Tsai SB; Qiu A
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29039781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Transformational Leadership on Firm Performance: Mediating Effect of Corporate Sustainability and Moderating Effect of Knowledge-Sharing.
    Shahzad MA; Iqbal T; Jan N; Zahid M
    Front Psychol; 2022; 13():883224. PubMed ID: 35874334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Employee Stock Ownership Plans Affect Corporate Social Responsibility? Evidence from China.
    Zhou L; Wei F; Kong Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical leadership, corporate social responsibility, firm reputation, and firm performance: A serial mediation model.
    Nguyen NTT; Nguyen NP; Thanh Hoai T
    Heliyon; 2021 Apr; 7(4):e06809. PubMed ID: 33898855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.